Difficulty: Medium
Average Score: 72%
Practice
All the following inhalation therapies in cystic fibrosis are true EXCEPT:
Correct answer
A
Rationale
In cystic fibrosis (CF), a genetic disorder affecting the respiratory system, inhalation therapies play a crucial role in managing symptoms. The correct answer, A) β-agonists may decrease PaO2, is true because while β-agonists can help dilate airways, they may also cause decreased PaO2 levels in CF patients due to ventilation-perfusion mismatch.
Option B) human recombinant DNase improves pulmonary function is correct as DNase helps break down DNA in sputum, reducing viscosity and improving airway clearance. This therapy has shown to be effective in CF management.
Option C) N-acetylcysteine is toxic to ciliated epithelium is incorrect. N-acetylcysteine is a mucolytic agent that helps break down mucus in CF patients, aiding in clearance and reducing the risk of infections.
Option D) nebulized hypertonic saline improves mucociliary clearance is also true. Hypertonic saline helps hydrate airway surfaces, thinning mucus and promoting clearance, which is beneficial for CF patients.
Educationally, understanding the rationale behind each inhalation therapy in CF is vital for nurses to provide effective care. Knowing the mechanisms of action, benefits, and potential side effects of these therapies helps ensure safe and evidence-based practice in pediatric respiratory nursing.
Option B) human recombinant DNase improves pulmonary function is correct as DNase helps break down DNA in sputum, reducing viscosity and improving airway clearance. This therapy has shown to be effective in CF management.
Option C) N-acetylcysteine is toxic to ciliated epithelium is incorrect. N-acetylcysteine is a mucolytic agent that helps break down mucus in CF patients, aiding in clearance and reducing the risk of infections.
Option D) nebulized hypertonic saline improves mucociliary clearance is also true. Hypertonic saline helps hydrate airway surfaces, thinning mucus and promoting clearance, which is beneficial for CF patients.
Educationally, understanding the rationale behind each inhalation therapy in CF is vital for nurses to provide effective care. Knowing the mechanisms of action, benefits, and potential side effects of these therapies helps ensure safe and evidence-based practice in pediatric respiratory nursing.